Search Results 71-80 of 17306 for colitis
Inflammatory bowel disease is a group of autoimmune diseases that include ulcerative colitis and Crohn's disease. In inflammatory bowel disease, the immune ...
... Crohn's disease and ulcerative colitis, and that inflammatory bowel disease is an emerging public health problem. "The most recent estimates would be that ...
Subjects with Ulcerative Colitis who have completed an induction study with PF-00547659 will receive an additional 72 weeks of open-label treatment to ...
Mesalamineenema is used to treat active mild to moderate ulcerative colitis, proctitis or proctosigmoiditis (inflammation of the rectum and bowel). It works ...
The purpose of this study is to evaluate the safety, effectovemess, and microbiota changes of VE202 in patients with mild to moderate ulcerative colitis (UC).
This study is an open label, long-term extension study for subjects with moderate to severe ulcerative colitis designed to evaluate long term therapy of CP- ...
... ulcerative colitis (UC). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...
The Food and Drug Administration approved the use of anti-tumor necrosis factor and anti-integrin agents for the treatment of ulcerative colitis in 2005 ...
When compared with individuals from the general population, individuals with all forms of IBD studied (Crohn's disease, ulcerative colitis, with or without ...
Evaluation of the Relationship Between Pouch Function and Pouch Inflammation in Patients with Ulcerative Colitis · Overview · Participation eligibility.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.